The Global Tendonitis Treatment Market will Hit $252.3 Billion by 2028, at a CAGR of 3.7%

Published Date: 30-Nov-2022

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Tendonitis Treatment Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Tendonitis Treatment Market size is expected to reach $252.3 billion by 2028, rising at a market growth of 3.7% CAGR during the forecast period.

The Therapy segment acquired maximum revenue share in the Global Tendonitis Treatment Market by Type in 2021 thereby, achieving a market value of $168.2 billion by 2028. The preference of tendonitis patients for non-invasive therapies is seen to be a factor in the segment's rise. Because it is the first line of treatment for tendonitis and helps patients with chronic tendon problems, the physical therapy sub-segment held the biggest market share in the therapy category.

The Jumper’s Knee segment is showcasing a CAGR of 3.9% during (2022 - 2028). Overusing the knee joint, such as by repeatedly jumping on hard surfaces, can result in a jumper's knee. The best course of action for the jumper's knee is to cease all aggravating activities until the condition has healed. Nonsteroidal anti-inflammatory medications and heat & cold therapy are examples of other treatments.

The North America market dominated the Global Tendonitis Treatment Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $102.9 billion by 2028.The Europe market is exhibiting a CAGR of 3.4% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 4.4% during (2022 - 2028).

Full Report:

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Merck & Co., Inc., Bayer AG, AstraZeneca PLC, Boehringer Ingelheim International GmbH, Abbott Laboratories, Pfizer, Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., and Almatica Pharma, Inc.

Global Tendonitis Treatment Market Segmentation

By Type

  • Therapy
    • Physical Therapy
    • Hot & Cold Therapy
    • Shockwave Therapy
  • Surgery

By Condition

  • Achilles Tendonitis
  • Jumper’s Knee
  • Tennis Elbow
  • Pitcher’s Elbow
  • Swimmer’s Shoulder
  • Golfer’s Elbow

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Australia
    • Rest of Asia Pacific
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Merck & Co., Inc.
  • Bayer AG
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Abbott Laboratories
  • Pfizer, Inc.
  • GlaxoSmithKline PLC
  • Teva Pharmaceuticals Industries Ltd.
  • Almatica Pharma, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

North America Tendonitis Treatment Market size & Opportunities 2022-2028

Europe Tendonitis Treatment Market & Growth Forecast 2022-2028

Asia Pacific Tendonitis Treatment Market Share & Industry Outlook to 2028

LAMEA Tendonitis Treatment Market Growth, Trends & Forecasts 2022-2028

Request a Free Sample Copy

Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.